News About: Pharm. Industry
Jeil's TS-1 may shake whole cancer drug markets.
Jeil Pharmaceutical Co. will introduce an attractive ant-cancer drug named TS-1 formulated with 3 components such as Tegaflu, Kimeracil and Oteracil under the technical licence with Japanese Taiho who originally devel...
Domestic drug-related patent applications plunged 47% in 2002
Recent statistics showed that Korea's drug-related patents applications in 2002 toped 404 cases, down 448 cases compared with 852 cases from a year earlier, meaning that the domestic pharmaceutical business en...
Boryung to implement ethical management.
Chairman Kim Seung-ho of Boryung announced "The Ethical Management Guideline for the company executives and staffs" on Jan. 29 so that all company members should keep their ethical decision making and action in their ...
Tightened tax rules hit domestic pharmaceutical firms
Beginning in 2004, the National Tax Service says companies that spend 500,000 won or more entertaining their customers, clients or employees must prove that the meetings are business-related, while people on the recei...
7 companies fined on charge of hospital bid rigging.
In earlier government's public bidding for the purchase of vaccines, 7 drug companies were accused of a bid rigging and fined thereof.
Fair Trade Commission (FTC) inspected the public bidding process for the purcha...
Speedy listing of Iressa's insurance price urged
In a recent meeting with the local Health World Network over the pending health insurance price of Iressa, an anticancer agent, AstraZeneca Korea said that the government is still in the process of assessing its reimb...
Abbott Korea launches obesity-free company campaign
Abbott Korea, a pharmaceutical maker of Reductil (sibutramine hydrochloride monohydrate) intended for the management of obesity, said recently its ongoing obesity-free company campaign is gaining positive response fro...
Earlier introduction of generic drug becomes critical to survive.
To keep the prescription drug markets and to survive from harsh competitive environments, an earlier introduction of generic drugs than other rivals will be one of the most critical strategy for the domestic drug corp...
Yuhan achieved 7.5% sales growth with 8.3% net profits in 2003.
The 2003 Yuhan annual management report revealed 305.5 billion won of the sales (7.5% over the previous year), 45.7 billion won of gross profits (2.0% growth), 76.3 billion won of ordinary income (9.8%) and 49.5 billi...
Brand marketing essential in modern marketplace
With the prevailing understanding that brand image is a means of controlling not only an organization but also influencing the minds of customers, it is often argued that domestic pharmaceutical firms should reflect t...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
